Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 189.2M | $ 61.94M | 32.74% |
3/31/2025 | $ 195.78M | $ 48.29M | 24.66% |
12/31/2024 | $ 159.39M | $ 17.5M | 10.98% |
9/30/2024 | $ 197.52M | $ 29.96M | 15.17% |
6/30/2024 | $ 215.78M | $ 19.33M | 8.96% |
3/31/2024 | $ 269.12M | $ 18.87M | 7.01% |
12/31/2023 | $ 293.48M | $ 45.03M | 15.34% |
9/30/2023 | $ 308.22M | $ 76.49M | 24.82% |
6/30/2023 | $ 253.59M | $ 141.09M | 55.64% |
3/31/2023 | $ 280.72M | $ 185.88M | 66.22% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ATAI LIFE SCIENCES NV is calculated as follows: CashnEq [ $ 97.25M ] / Assets [ $ 111.55M ]
(=) Cash to Assets [ 87.18% ]
Minimum
Mar 31, 2024
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |